In summary, we have demonstrated a novel anti-proliferative effect of M1R activation in human colon cancer cells that may explain why CHRM1/M1R levels in colon cancer are relatively reduced compared to CHRM3/M3R levels. The gene discussed is CHRM3; the disease is malignant colon neoplasm.